Objective To discuss how the clinical pharmacists participated in the treatment of pediatric purulent meningi-tis and conducted drug monitoring.Methods Clinical pharmacists involved the whole process of treatment for a purulent men-ingitis infant with renal insufficiency,evaluated medication history,conducted therapeutic drug monitoring and designed an in-dividualized medication treatment plan with clinical physicians.Results Clinical pharmacists assisted clinicians with their phar-macy expertise,and developed individualized drug dosing regimen to achieve effective therapy and medication safety.Conclusion Clinical pharmacists play an important role in providing individualized pharmaceutical care for patients,optimizing the treat-ment plan and improving the rational drug use.

The membrane protein claudin-3 (CLDN3) is critical for the formation and maintenance of tight junction and its high expression has been implicated in dictating malignant progression in various cancers. However, the post-translational modification of CLDN3 and its biological function remains poorly understood. Here, we report that CLDN3 is positively correlated with ovarian cancer progression both and Of interest, CLDN3 undergoes -palmitoylation on three juxtamembrane cysteine residues, which contribute to the accurate plasma membrane localization and protein stability of CLDN3 Moreover, the deprivation of -palmitoylation in CLDN3 significantly abolishes its tumorigenic promotion effect in ovarian cancer cells. By utilizing the co-immunoprecipitation assay, we further identify ZDHHC12 as a CLDN3-targating palmitoyltransferase from 23 ZDHHC family proteins. Furthermore, the knockdown of ZDHHC12 also significantly inhibits CLDN3 accurate membrane localization, protein stability and ovarian cancer cells tumorigenesis Thus, our work reveals -palmitoylation as a novel regulatory mechanism that modulates CLDN3 function, which implies that targeting ZDHHC12-mediated CLDN3 -palmitoylation might be a potential strategy for ovarian cancer therapy.